Livagen 20 mg

Product Overview

Livagen 20 mg is a synthetic bioregulatory peptide designed to support liver function, detoxification processes, and cellular regeneration. It is part of a class of short peptides that modulate gene expression in specific tissues, particularly hepatocytes.

Manufactured by Dragon Pharma, Livagen is widely studied for its hepatoprotective and metabolic regulatory effects in research and performance contexts.

Drug Class

Livagen belongs to the class of bioregulatory peptides, specifically targeting liver function and metabolic regulation.

Indications

Primary Uses (Research Context)

• Liver support and detoxification
• Hepatocyte regeneration
• Protection against liver stress

Secondary Uses

• Metabolic optimization
• Support during hepatotoxic compound use
• General health and anti-aging protocols

Mechanism of Action

Livagen works through peptide-mediated cellular regulation:

• Modulates gene expression in liver cells
• Promotes hepatocyte repair and regeneration
• Enhances detoxification pathways
• Supports metabolic balance

Dosage & Administration

• Typical research dosing: 5–10 mg daily or protocol-dependent
• Administered via subcutaneous or intramuscular injection
• Cycle duration: 2–4 weeks commonly used

Note: Not approved for general therapeutic use; dosing varies.

Pharmacokinetics

• Rapid absorption following injection
• Short plasma half-life
• Prolonged cellular effects via gene modulation

Effects & Benefits

• Enhanced liver detoxification
• Support of liver regeneration
• Improved metabolic function
• Protection against hepatotoxic stress

Synergy & Stacking

Livagen is commonly used in combination with other compounds for comprehensive liver and metabolic support:

• TUDCA / UDCA: Supports bile flow and liver protection
• NAC (N-acetylcysteine): Enhances antioxidant capacity
• Glutathione: Supports detoxification pathways
• HGH: Promotes regenerative processes

Stacking is particularly beneficial during or after exposure to hepatotoxic compounds.

HRT/TRT Relevance

Livagen is often used in TRT or anabolic protocols to support liver health and mitigate potential hepatotoxic effects.

Use in Females

This peptide is non-hormonal and generally suitable for females in research settings.

Pre-Cycle Requirements

• Liver function tests (ALT, AST)
• Metabolic panel
• Assessment of liver health status

Comparative Analysis

Compared to traditional liver support agents:

• Livagen: Targets gene expression and cellular repair
• NAC/TUDCA: Support detoxification pathways
• Potentially complementary rather than replacement therapy

Effectiveness

Livagen shows promising hepatoprotective effects in research settings, particularly for supporting liver regeneration and metabolic balance, though clinical evidence is limited.

Risk Management

Common Observations

• Mild injection site irritation
• Minimal systemic side effects

Potential Risks

• Limited long-term safety data
• Variable response depending on liver condition

Mitigation Strategies

• Monitor liver function regularly
• Use within recommended protocols
• Avoid excessive dosing

Drug Interactions

• Other hepatoprotective agents
• Metabolic-modulating compounds

Conclusion

Livagen 20 mg is a targeted bioregulatory peptide designed to support liver health, detoxification, and cellular regeneration. It is particularly useful in protocols involving metabolic stress or hepatotoxic exposure.